184 related articles for article (PubMed ID: 23777634)
1. Genome-wide expression profiling and functional characterization of SCA28 lymphoblastoid cell lines reveal impairment in cell growth and activation of apoptotic pathways.
Mancini C; Roncaglia P; Brussino A; Stevanin G; Lo Buono N; Krmac H; Maltecca F; Gazzano E; Bartoletti Stella A; Calvaruso MA; Iommarini L; Cagnoli C; Forlani S; Le Ber I; Durr A; Brice A; Ghigo D; Casari G; Porcelli AM; Funaro A; Gasparre G; Gustincich S; Brusco A
BMC Med Genomics; 2013 Jun; 6():22. PubMed ID: 23777634
[TBL] [Abstract][Full Text] [Related]
2. Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
Mancini C; Hoxha E; Iommarini L; Brussino A; Richter U; Montarolo F; Cagnoli C; Parolisi R; Gondor Morosini DI; Nicolò V; Maltecca F; Muratori L; Ronchi G; Geuna S; Arnaboldi F; Donetti E; Giorgio E; Cavalieri S; Di Gregorio E; Pozzi E; Ferrero M; Riberi E; Casari G; Altruda F; Turco E; Gasparre G; Battersby BJ; Porcelli AM; Ferrero E; Brusco A; Tempia F
Neurobiol Dis; 2019 Apr; 124():14-28. PubMed ID: 30389403
[TBL] [Abstract][Full Text] [Related]
3. Purkinje neuron Ca2+ influx reduction rescues ataxia in SCA28 model.
Maltecca F; Baseggio E; Consolato F; Mazza D; Podini P; Young SM; Drago I; Bahr BA; Puliti A; Codazzi F; Quattrini A; Casari G
J Clin Invest; 2015 Jan; 125(1):263-74. PubMed ID: 25485680
[TBL] [Abstract][Full Text] [Related]
4. Spinocerebellar ataxia type 28 (SCA28) is an uncommon cause of dominant ataxia among Chinese kindreds.
Jia D; Tang B; Chen Z; Shi Y; Sun Z; Zhang L; Wang J; Xia K; Jiang H
Int J Neurosci; 2012 Oct; 122(10):560-2. PubMed ID: 22563911
[TBL] [Abstract][Full Text] [Related]
5. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases.
Pierson TM; Adams D; Bonn F; Martinelli P; Cherukuri PF; Teer JK; Hansen NF; Cruz P; Mullikin For The Nisc Comparative Sequencing Program JC; Blakesley RW; Golas G; Kwan J; Sandler A; Fuentes Fajardo K; Markello T; Tifft C; Blackstone C; Rugarli EI; Langer T; Gahl WA; Toro C
PLoS Genet; 2011 Oct; 7(10):e1002325. PubMed ID: 22022284
[TBL] [Abstract][Full Text] [Related]
6. Partial deletion of AFG3L2 causing spinocerebellar ataxia type 28.
Smets K; Deconinck T; Baets J; Sieben A; Martin JJ; Smouts I; Wang S; Taroni F; Di Bella D; Van Hecke W; Parizel PM; Jadoul C; De Potter R; Couvreur F; Rugarli E; De Jonghe P
Neurology; 2014 Jun; 82(23):2092-100. PubMed ID: 24814845
[TBL] [Abstract][Full Text] [Related]
7. Spinocerebellar Ataxia Type 28-Phenotypic and Molecular Characterization of a Family with Heterozygous and Compound-Heterozygous Mutations in AFG3L2.
Tunc S; Dulovic-Mahlow M; Baumann H; Baaske MK; Jahn M; Junker J; Münchau A; Brüggemann N; Lohmann K
Cerebellum; 2019 Aug; 18(4):817-822. PubMed ID: 31111429
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
Tulli S; Del Bondio A; Baderna V; Mazza D; Codazzi F; Pierson TM; Ambrosi A; Nolte D; Goizet C; Toro C; Baets J; Deconinck T; DeJonghe P; Mandich P; Casari G; Maltecca F
J Med Genet; 2019 Aug; 56(8):499-511. PubMed ID: 30910913
[TBL] [Abstract][Full Text] [Related]
9. A novel frameshift mutation in the AFG3L2 gene in a patient with spinocerebellar ataxia.
Musova Z; Kaiserova M; Kriegova E; Fillerova R; Vasovcak P; Santava A; Mensikova K; Zumrova A; Krepelova A; Sedlacek Z; Kanovsky P
Cerebellum; 2014 Jun; 13(3):331-7. PubMed ID: 24272953
[TBL] [Abstract][Full Text] [Related]
10. Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias.
Cagnoli C; Stevanin G; Brussino A; Barberis M; Mancini C; Margolis RL; Holmes SE; Nobili M; Forlani S; Padovan S; Pappi P; Zaros C; Leber I; Ribai P; Pugliese L; Assalto C; Brice A; Migone N; Dürr A; Brusco A
Hum Mutat; 2010 Oct; 31(10):1117-24. PubMed ID: 20725928
[TBL] [Abstract][Full Text] [Related]
11. Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism and optic atrophy with aberrant OPA1 processing and mitochondrial network fragmentation.
Magri S; Fracasso V; Plumari M; Alfei E; Ghezzi D; Gellera C; Rusmini P; Poletti A; Di Bella D; Elia AE; Pantaleoni C; Taroni F
Hum Mutat; 2018 Dec; 39(12):2060-2071. PubMed ID: 30252181
[TBL] [Abstract][Full Text] [Related]
12. Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28.
Gorman GS; Pfeffer G; Griffin H; Blakely EL; Kurzawa-Akanbi M; Gabriel J; Sitarz K; Roberts M; Schoser B; Pyle A; Schaefer AM; McFarland R; Turnbull DM; Horvath R; Chinnery PF; Taylor RW
JAMA Neurol; 2015 Jan; 72(1):106-11. PubMed ID: 25420100
[TBL] [Abstract][Full Text] [Related]
13. Expanding the phenotype of AFG3L2 mutations: Late-onset autosomal recessive spinocerebellar ataxia.
Chiang HL; Fuh JL; Tsai YS; Soong BW; Liao YC; Lee YC
J Neurol Sci; 2021 Sep; 428():117600. PubMed ID: 34333379
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive Characterization of an SCA28 Family Caused by a Novel AFG3L2 Gene Mutation.
Szpisjak L; Nemeth VL; Szepfalusi N; Zadori D; Maroti Z; Kalmar T; Vecsei L; Klivenyi P
Cerebellum; 2017 Dec; 16(5-6):979-985. PubMed ID: 28660440
[No Abstract] [Full Text] [Related]
15. Mitochondrial hyperfusion induced by loss of the fission protein Drp1 causes ATM-dependent G2/M arrest and aneuploidy through DNA replication stress.
Qian W; Choi S; Gibson GA; Watkins SC; Bakkenist CJ; Van Houten B
J Cell Sci; 2012 Dec; 125(Pt 23):5745-57. PubMed ID: 23015593
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28.
Di Bella D; Lazzaro F; Brusco A; Plumari M; Battaglia G; Pastore A; Finardi A; Cagnoli C; Tempia F; Frontali M; Veneziano L; Sacco T; Boda E; Brussino A; Bonn F; Castellotti B; Baratta S; Mariotti C; Gellera C; Fracasso V; Magri S; Langer T; Plevani P; Di Donato S; Muzi-Falconi M; Taroni F
Nat Genet; 2010 Apr; 42(4):313-21. PubMed ID: 20208537
[TBL] [Abstract][Full Text] [Related]
17. Sustained OMA1-mediated integrated stress response is beneficial for spastic ataxia type 5.
Franchino CA; Brughera M; Baderna V; De Ritis D; Rocco A; Seneca S; Regal L; Podini P; D'Antonio M; Toro C; Quattrini A; Scalais E; Maltecca F
Brain; 2024 Mar; 147(3):1043-1056. PubMed ID: 37804316
[TBL] [Abstract][Full Text] [Related]
18. AFG3L2 supports mitochondrial protein synthesis and Purkinje cell survival.
Almajan ER; Richter R; Paeger L; Martinelli P; Barth E; Decker T; Larsson NG; Kloppenburg P; Langer T; Rugarli EI
J Clin Invest; 2012 Nov; 122(11):4048-58. PubMed ID: 23041622
[TBL] [Abstract][Full Text] [Related]
19. Novel role of androgens in mitochondrial fission and apoptosis.
Choudhary V; Kaddour-Djebbar I; Lakshmikanthan V; Ghazaly T; Thangjam GS; Sreekumar A; Lewis RW; Mills IG; Bollag WB; Kumar MV
Mol Cancer Res; 2011 Aug; 9(8):1067-77. PubMed ID: 21724752
[TBL] [Abstract][Full Text] [Related]
20. SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber Atrophy.
Svenstrup K; Nielsen TT; Aidt F; Rostgaard N; Duno M; Wibrand F; Vinther-Jensen T; Law I; Vissing J; Roos P; Hjermind LE; Nielsen JE
Cerebellum; 2017 Feb; 16(1):62-67. PubMed ID: 26868664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
